Table 5.
Proportion of patients that achieved lipid goals in the simulation analysis (ideal scenario where everyone received appropriate doses of statins ± ezetimibe).
| Lipid Goals | Moderate Risk n = 13 n (%) |
High Risk n = 229 n (%) |
Very High Risk n = 286 n (%) |
|---|---|---|---|
| Adding statins at appropriate doses | |||
| LDL-C < 55 mg/dL | 100 (35.5) | ||
| Non-HDL-C < 85 mg/dL | 103 (36.0) | ||
| LDL-C < 70 mg/dL | 130 (56.8) | ||
| Non-HDL-C < 100 mg/dL | 132 (57.2) | ||
| LDL-C < 100 mg/dL | 13 (100) | ||
| Non-HDL-C < 130 mg/dL | 13 (100) | ||
| Adding ezetimibe | |||
| LDL-C < 55 mg/dL | 129 (45.1) | ||
| Non-HDL-C < 85 mg/dL | 148 (51.8) | ||
| LDL-C < 70 mg/dL | 156 (68.1) | ||
| Non-HDL-C < 100mg/dL | 168 (73.2) | ||
| LDL-C < 100 mg/dL | not applicable | ||
| Non-HDL-C < 130 mg/dL | not applicable |